GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totaling 13,670 shares, a drop of 40.8% from the April 30th total of 23,087 shares. Based on an average daily volume of 97,480 shares, the days-to-cover ratio is currently 0.1 days.
GeneDx Stock Performance
Shares of WGSWW stock traded down $0.00 on Wednesday, hitting $0.00. The stock had a trading volume of 208,536 shares, compared to its average volume of 73,693. GeneDx has a 12-month low of $0.00 and a 12-month high of $0.13. The business has a 50 day moving average of $0.01 and a 200 day moving average of $0.02.
About GeneDx
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Articles
- Five stocks we like better than GeneDx
- Motorola’s $1.5B Bet to Own the Skies
- AI’s Power Crunch Is Putting Uranium Energy Back on Investors’ Watchlists
- What IBM’s $10-Billion Quantum Project Means For Smaller Players
- HIVE Earnings Highlight AI Ambitions Beyond Bitcoin Mining
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
